Literature DB >> 16699787

Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's disease.

D C Duke1, L B Moran, M E Kalaitzakis, M Deprez, D T Dexter, R K B Pearce, M B Graeber.   

Abstract

There is growing evidence that dysfunction of the mitochondrial respiratory chain and failure of the cellular protein degradation machinery, specifically the ubiquitin-proteasome system, play an important role in the pathogenesis of Parkinson's disease. We now show that the corresponding pathways of these two systems are linked at the transcriptomic level in Parkinsonian substantia nigra. We examined gene expression in medial and lateral substantia nigra (SN) as well as in frontal cortex using whole genome DNA oligonucleotide microarrays. In this study, we use a hypothesis-driven approach in analysing microarray data to describe the expression of mitochondrial and ubiquitin-proteasomal system (UPS) genes in Parkinson's disease (PD). Although a number of genes showed up-regulation, we found an overall decrease in expression affecting the majority of mitochondrial and UPS sequences. The down-regulated genes include genes that encode subunits of complex I and the Parkinson's-disease-linked UCHL1. The observed changes in expression were very similar for both medial and lateral SN and also affected the PD cerebral cortex. As revealed by "gene shaving" clustering analysis, there was a very significant correlation between the transcriptomic profiles of both systems including in control brains. Therefore, the mitochondria and the proteasome form a higher-order gene regulatory network that is severely perturbed in Parkinson's disease. Our quantitative results also suggest that Parkinson's disease is a disease of more than one cell class, i.e. that it goes beyond the catecholaminergic neuron and involves glia as well.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699787     DOI: 10.1007/s10048-006-0033-5

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  52 in total

1.  The human genome: gene expression profiling and schizophrenia.

Authors:  K Mirnics; F A Middleton; D A Lewis; P Levitt
Journal:  Am J Psychiatry       Date:  2001-09       Impact factor: 18.112

2.  Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover.

Authors:  Patrick G Sullivan; Natasa B Dragicevic; Jian-Hong Deng; Yidong Bai; Edgardo Dimayuga; Qunxing Ding; Qinghua Chen; Annadora J Bruce-Keller; Jeffrey N Keller
Journal:  J Biol Chem       Date:  2004-01-22       Impact factor: 5.157

3.  Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease.

Authors:  Kevin St P McNaught; Daniel P Perl; Anna-Liisa Brownell; C Warren Olanow
Journal:  Ann Neurol       Date:  2004-07       Impact factor: 10.422

4.  Glia cell number modulates sensitivity to MPTP in mice.

Authors:  Michelle Smeyne; Yun Jiao; Kennie R Shepherd; Richard J Smeyne
Journal:  Glia       Date:  2005-11-01       Impact factor: 7.452

5.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease.

Authors:  R Betarbet; T B Sherer; G MacKenzie; M Garcia-Osuna; A V Panov; J T Greenamyre
Journal:  Nat Neurosci       Date:  2000-12       Impact factor: 24.884

6.  Lewy bodies.

Authors:  L S Forno
Journal:  N Engl J Med       Date:  1986-01-09       Impact factor: 91.245

7.  Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.

Authors:  P M Mattila; J O Rinne; H Helenius; D W Dickson; M Röyttä
Journal:  Acta Neuropathol       Date:  2000-09       Impact factor: 17.088

8.  Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease.

Authors:  Günter U Höglinger; Géraldine Carrard; Patrick P Michel; Fadia Medja; Anne Lombès; Merle Ruberg; Bertrand Friguet; Etienne C Hirsch
Journal:  J Neurochem       Date:  2003-09       Impact factor: 5.372

9.  Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.

Authors:  Vincenzo Bonifati; Patrizia Rizzu; Marijke J van Baren; Onno Schaap; Guido J Breedveld; Elmar Krieger; Marieke C J Dekker; Ferdinando Squitieri; Pablo Ibanez; Marijke Joosse; Jeroen W van Dongen; Nicola Vanacore; John C van Swieten; Alexis Brice; Giuseppe Meco; Cornelia M van Duijn; Ben A Oostra; Peter Heutink
Journal:  Science       Date:  2002-11-21       Impact factor: 47.728

10.  Altered proteasomal function in sporadic Parkinson's disease.

Authors:  Kevin St P McNaught; Roger Belizaire; Ole Isacson; Peter Jenner; C Warren Olanow
Journal:  Exp Neurol       Date:  2003-01       Impact factor: 5.330

View more
  35 in total

Review 1.  Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.

Authors:  Sharawan Yadav; Anubhuti Dixit; Sonal Agrawal; Ashish Singh; Garima Srivastava; Anand Kumar Singh; Pramod Kumar Srivastava; Om Prakash; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2012-06-27       Impact factor: 5.590

2.  Up-regulation of metallothionein gene expression in parkinsonian astrocytes.

Authors:  Gregory J Michael; Sharmin Esmailzadeh; Linda B Moran; Lynne Christian; Ronald K B Pearce; Manuel B Graeber
Journal:  Neurogenetics       Date:  2011-07-29       Impact factor: 2.660

3.  Molecular markers of early Parkinson's disease based on gene expression in blood.

Authors:  Clemens R Scherzer; Aron C Eklund; Lee J Morse; Zhixiang Liao; Joseph J Locascio; Daniel Fefer; Michael A Schwarzschild; Michael G Schlossmacher; Michael A Hauser; Jeffery M Vance; Lewis R Sudarsky; David G Standaert; John H Growdon; Roderick V Jensen; Steven R Gullans
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-10       Impact factor: 11.205

Review 4.  Concise review: new paradigms for Down syndrome research using induced pluripotent stem cells: tackling complex human genetic disease.

Authors:  James A Briggs; Elizabeth A Mason; Dmitry A Ovchinnikov; Christine A Wells; Ernst J Wolvetang
Journal:  Stem Cells Transl Med       Date:  2013-02-14       Impact factor: 6.940

5.  Gene expression profiles of mouse striatum in control and maneb + paraquat-induced Parkinson's disease phenotype: validation of differentially expressed energy metabolizing transcripts.

Authors:  Suman Patel; Kavita Singh; Seema Singh; Mahendra Pratap Singh
Journal:  Mol Biotechnol       Date:  2008-04-02       Impact factor: 2.695

6.  Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.

Authors:  Filip Simunovic; Ming Yi; Yulei Wang; Laurel Macey; Lauren T Brown; Anna M Krichevsky; Susan L Andersen; Robert M Stephens; Francine M Benes; Kai C Sonntag
Journal:  Brain       Date:  2008-12-03       Impact factor: 13.501

7.  SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease.

Authors:  Lina A Shehadeh; Kristine Yu; Liyong Wang; Alexandra Guevara; Carlos Singer; Jeffery Vance; Spyridon Papapetropoulos
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

Review 8.  The ubiquitin-proteasome system in spongiform degenerative disorders.

Authors:  Brandi R Whatley; Lian Li; Lih-Shen Chin
Journal:  Biochim Biophys Acta       Date:  2008-08-23

Review 9.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

10.  Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease.

Authors:  Vellareddy Anantharam; Elin Lehrmann; Arthi Kanthasamy; Yongjie Yang; Probal Banerjee; Kevin G Becker; William J Freed; Anumantha G Kanthasamy
Journal:  Neurochem Int       Date:  2007-02-23       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.